Virus News and Research

Latest Virus News and Research

Specific immune signature identified in COVID-19 patients

Researchers at King’s College London and collaborators have identified an “immune signature” that could help researchers better understand coronavirus disease 2019 (COVID-19) and serve as a valuable resource for predicting patient prognosis and informing clinical risk-based stratification.

10 Jun 2020

Mitigating "second wave" COVID-19 risk to health frontliners and patients

Researchers at University College London have made important discoveries about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among frontline healthcare workers that could help to inform new policies for protecting staff and patients in the future.

10 Jun 2020

G42 and Oxford Nanopore co-develop population-scale technology to detect SARS-CoV-2

Group 42 (G42), a leading AI and Cloud Computing company based in the United Arab Emirates, and Oxford Nanopore Technologies, an advanced sequencing technology company based in the United Kingdom, announced today they have developed an unprecedented population-scale technology that rapidly and accurately detects SARS-CoV-2, the virus that causes COVID-19.

10 Jun 2020

Coronavirus (COVID-19) sample tracking packages

To assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy for dealing with the SARS-CoV-2 virus pandemic – Ziath has introduced two optimized packages for reliable tracking of patient samples submitted for Coronavirus (COVID-19) testing.

From Ziath Ltd 10 Jun 2020

Internet searches can help track the spread of COVID-19, says UofL researcher

When they're feeling sick, many people turn to the Internet. They Google their symptoms - headache, chest pain, shortness of breath - hoping to learn more about what's happening in their bodies.

10 Jun 2020

Immuno-oncology may accelerate the development of treatments for COVID-19

Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or other control strategies that can help communities worldwide to address the impacts of the COVID-19 pandemic.

10 Jun 2020

Virologists develop new methods to inactivate and study SARS-Cov-2

Detailed methods on how to perform research on SARS-CoV-2, the virus that causes COVID-19, including procedures that effectively inactivate the virus to enable the safe study of infected cells have been identified by virologists in the Institute for Biomedical Sciences at Georgia State University.

10 Jun 2020

Role of nuclear cardiology in COVID-19

"We know that without a vaccine we're going to be dealing with this virus for a while," said Johnese Spisso, president of UCLA Health, in an interview with Johannes Czernin.

10 Jun 2020

The 1918 flu pandemic can help mitigate the spread of COVID-19

What can the 1918 flu pandemic teach people about the current COVID-19 pandemic? That's what a group of researchers at the University of Missouri hope to uncover with the help of a recent COVID-19 RAPID grant from the National Science Foundation.

10 Jun 2020

Research reveals 7 different SARS-CoV-2 strains arrived in California

The coronavirus disease (COVID-19) first emerged in Wuhan City in China in December 2019. From there, it has actively spread across the globe. The United States has been the hardest-hit country in the pandemic, with more than 1.97 million people infected.

10 Jun 2020

COVID-19 lockdowns estimated to have prevented 3 million deaths across 11 European countries

Now, a new study by researchers at Imperial College London estimates that lockdowns prevented around 3.1 million deaths in 11 European countries. The modeling study, published in the journal Nature, highlights that social distancing measures worked in reducing the spread of the virus.

10 Jun 2020

Study provides molecular explanation to a longstanding mystery in viral oncology

The oncogenic herpesvirus (HHV8 or KSHV) causes a cancer known as Kaposi's Sarcoma. An international team of scientists led by the University of Helsinki has discovered key factors that control the genome maintenance and replication of a virus responsible for lymphatic vascular cancer.

10 Jun 2020

Researchers examine the drying time of virus' droplets on various surfaces

One of the many questions researchers have about COVID-19 is how long the coronavirus causing the disease remains alive after someone infected with it coughs or sneezes.

10 Jun 2020

A confluence of aesthetic and analytics in theoretical biology

The book is a confluence of aesthetic and analytics in theoretical biology, which continues to be somewhat inaccessible for many despite its significant contributions to the scientific understanding of nature, biology, and medicine.

10 Jun 2020

Pollen contributes to flu and COVID-19 seasonality

The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.

10 Jun 2020

Deep UV LED inactivation of SARS-CoV-2 - fast and effective

The ongoing pandemic has aroused considerable effort to find methods to prevent and control the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19 disease. Rapid inactivation devices would be of great help in this area, to prevent viral transmission through aerosols and contact with infected surfaces.

9 Jun 2020

Lockdowns combined with widespread use of facemasks can stop the resurgence of SARS-CoV-2

Population-wide use of facemasks keeps the coronavirus 'reproduction number' under 1.0, and prevents further waves of the virus when combined with lockdowns, a modelling study from the universities of Cambridge and Greenwich suggests.

9 Jun 2020

Unique mutations could weaken Indian SARS-CoV-2 strain

A new study published on the preprint server bioRxiv in June 2020 suggests that the presence of unique mutations in the viral strains circulating in India has led to their attenuation.

9 Jun 2020

A drug to treat harsh complications of coronavirus infection is registered in Russia

Levilimab received state approval through a fast-track mechanism, according to Decree No. 441 of the Government of the Russian Federation of April 4, 2020, since its mechanism of action is associated with the control of the cytokine storm, which is one of the manifestations of coronavirus infection.

9 Jun 2020

Examining the effect of smoking, nicotine and vaping on COVID-19 severity

Researchers at the University of Oxford say they will be conducting the most extensive study to date linking primary and clinical data for the assessment of associations between smoking status and the severity of coronavirus disease 2019 (COVID-19).

9 Jun 2020